Fisher & Paykel Healthcare (OTCMKTS:FSPKF) Shares Up 3.2% – Should You Buy?

Shares of Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) shot up 3.2% during mid-day trading on Tuesday . The stock traded as high as $23.02 and last traded at $23.02. 100 shares changed hands during mid-day trading, a decline of 96% from the average session volume of 2,831 shares. The stock had previously closed at $22.3125.

Wall Street Analyst Weigh In

Separately, Royal Bank Of Canada raised Fisher & Paykel Healthcare to a “sector perform” rating in a research report on Tuesday, February 24th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Fisher & Paykel Healthcare Price Performance

The firm’s 50-day simple moving average is $23.06 and its 200 day simple moving average is $21.62.

Fisher & Paykel Healthcare Company Profile

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that specializes in the design, manufacture and marketing of products and systems for respiratory care and the treatment of obstructive sleep apnea. Headquartered in Auckland, the company focuses on delivering therapeutic solutions that enhance patient outcomes across a range of acute and chronic respiratory conditions.

The company’s product portfolio includes humidification systems used in mechanical ventilation, high-flow nasal cannula therapy devices for adult and neonatal care, continuous positive airway pressure (CPAP) machines and interfaces for sleep apnea treatment, as well as medical devices for non-invasive ventilation.